Eli lilly goes all-in on vaccines with $3b+ triple acquisition push into infectious disease prevention
Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.
Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.
Sarin will focus on advancing scalable AI-driven platforms and strengthening the company’s global data science capabilities across healthcare and enterprise technology domains
Dual regulatory clearances for Sentire(R) Endoscopic surgical system strengthen the company’s expansion across Europe and Asia-Pacific in minimally invasive robotic surgery
AAV vectors are widely used in gene therapy for their strong therapeutic potential
The company is also highlighting early-stage innovation in antibody-drug conjugates and in vivo CAR-T therapy
The new CRS offering is delivered from WACKER’s Biotechnology Center in Munich
Biologics manufacturing veteran brings over two decades of expertise in biosimilars, GMP operations, and large-scale biopharmaceutical manufacturing
NGI will deliver full end-to-end workflows using both EpiFinder cNUC and EpiFinder GenomePro
A high-resolution CT scan with 0.5 mm slices was used to design a customised titanium implant tailored to the patient’s anatomy and bone loss pattern
The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval
Subscribe To Our Newsletter & Stay Updated